ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,995,455 | -74.2% | 22,727,274 | 0.0% | 0.24% | -77.3% |
| Q2 2023 | $11,590,910 | -19.0% | 22,727,274 | 0.0% | 1.07% | -9.3% |
| Q1 2023 | $14,318,183 | -2.9% | 22,727,274 | 0.0% | 1.18% | -19.1% |
| Q4 2022 | $14,752,274 | -62.3% | 22,727,274 | 0.0% | 1.45% | -54.0% |
| Q3 2022 | $39,091,000 | +38.7% | 22,727,274 | 0.0% | 3.16% | +81.7% |
| Q2 2022 | $28,182,000 | +90.1% | 22,727,274 | 0.0% | 1.74% | +116.6% |
| Q1 2022 | $14,827,000 | -70.1% | 22,727,274 | -50.0% | 0.80% | +47.9% |
| Q4 2021 | $49,545,000 | +19.8% | 45,454,548 | +100.0% | 0.54% | -56.7% |
| Q3 2021 | $41,364,000 | +3.4% | 22,727,274 | +50.0% | 1.25% | +20.1% |
| Q2 2021 | $40,000,000 | -26.7% | 15,151,516 | 0.0% | 1.04% | -49.5% |
| Q1 2021 | $54,545,000 | +42.9% | 15,151,516 | 0.0% | 2.07% | -67.6% |
| Q4 2020 | $38,182,000 | 0.0% | 15,151,516 | 0.0% | 6.38% | -20.2% |
| Q3 2020 | $38,182,000 | -23.2% | 15,151,516 | 0.0% | 7.99% | -36.9% |
| Q2 2020 | $49,697,000 | +33.9% | 15,151,516 | 0.0% | 12.67% | +26.2% |
| Q1 2020 | $37,121,000 | -48.1% | 15,151,516 | 0.0% | 10.04% | -36.2% |
| Q4 2019 | $71,515,000 | +10.3% | 15,151,516 | 0.0% | 15.74% | +80.9% |
| Q3 2019 | $64,848,000 | +1.2% | 15,151,516 | +37.9% | 8.70% | +12.0% |
| Q2 2019 | $64,050,000 | +51.4% | 10,986,258 | 0.0% | 7.77% | +48.4% |
| Q1 2019 | $42,297,000 | +105.9% | 10,986,258 | 0.0% | 5.24% | +191.6% |
| Q4 2018 | $20,544,000 | +88.2% | 10,986,258 | +222.1% | 1.80% | +118.4% |
| Q3 2018 | $10,914,000 | +6.0% | 3,410,500 | 0.0% | 0.82% | +86.4% |
| Q2 2018 | $10,300,000 | -23.0% | 3,410,500 | 0.0% | 0.44% | -35.0% |
| Q1 2018 | $13,369,000 | -5.3% | 3,410,500 | 0.0% | 0.68% | -7.5% |
| Q4 2017 | $14,119,000 | -32.6% | 3,410,500 | 0.0% | 0.73% | +20.0% |
| Q3 2017 | $20,940,000 | -1.3% | 3,410,500 | 0.0% | 0.61% | -53.7% |
| Q2 2017 | $21,213,000 | -1.9% | 3,410,500 | 0.0% | 1.32% | +22.6% |
| Q1 2017 | $21,623,000 | +18.5% | 3,410,500 | 0.0% | 1.08% | +17.7% |
| Q4 2016 | $18,246,000 | -5.0% | 3,410,500 | 0.0% | 0.92% | -40.9% |
| Q3 2016 | $19,201,000 | +2.5% | 3,410,500 | 0.0% | 1.55% | +26.9% |
| Q2 2016 | $18,724,000 | -29.1% | 3,410,500 | -4.2% | 1.22% | -11.8% |
| Q1 2016 | $26,404,000 | -21.7% | 3,558,500 | -12.3% | 1.38% | -3.1% |
| Q4 2015 | $33,726,000 | -15.1% | 4,058,500 | -7.9% | 1.43% | +9.3% |
| Q3 2015 | $39,721,000 | -26.0% | 4,408,500 | -1.5% | 1.31% | +20.6% |
| Q2 2015 | $53,700,000 | +12.7% | 4,475,000 | +1.1% | 1.08% | -3.6% |
| Q1 2015 | $47,657,000 | +128.2% | 4,425,000 | +7.4% | 1.12% | +128.2% |
| Q4 2014 | $20,886,000 | +187.7% | 4,119,611 | +49.8% | 0.49% | +126.1% |
| Q3 2014 | $7,260,000 | -34.5% | 2,750,000 | 0.0% | 0.22% | -24.8% |
| Q2 2014 | $11,083,000 | -12.0% | 2,750,000 | 0.0% | 0.29% | -39.3% |
| Q1 2014 | $12,595,000 | +5.5% | 2,750,000 | 0.0% | 0.48% | -1.8% |
| Q4 2013 | $11,935,000 | +163.4% | 2,750,000 | +139.1% | 0.49% | +184.8% |
| Q3 2013 | $4,531,000 | +86.7% | 1,150,000 | 0.0% | 0.17% | +28.6% |
| Q2 2013 | $2,427,000 | – | 1,150,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |